Evidence map›Paper›PMID 32749953›Full record

ArticleMicrobiology (Reading, England)2020

Laura M Nolan, Lynne Turnbull, Marilyn Katrib, Sarah R Osvath, Davide Losa, James J Lazenby, Cynthia B Whitchurch

Open access · hybridAbstract read
In one paragraph

Article in Microbiology (Reading, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Biochemistry · 2025
    Article
  6. Article
  7. Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2025
    Review
  8. Outbreak of Carbapenem-Resistant High-Risk Clone ST244 ofAntibiotics (Basel, Switzerland) · 2025
    Article
  9. Review
  10. Article
  11. Optimizing CaClCurrent genetics · 2024
    Article
  12. Antibiotics (Basel, Switzerland) · 2024
    Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Anti-Frontiers in microbiology · 2023
    Review
  19. Tolerance and resistance of microbial biofilms.Nature reviews. Microbiology · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Laura M NolanThe ithree institute, University of Technology Sydney, Ultimo, New South Wales, 2007, Australia.
Lynne TurnbullThe ithree institute, University of Technology Sydney, Ultimo, New South Wales, 2007, Australia.
Marilyn KatribThe ithree institute, University of Technology Sydney, Ultimo, New South Wales, 2007, Australia.
Sarah R OsvathThe ithree institute, University of Technology Sydney, Ultimo, New South Wales, 2007, Australia.
Davide LosaThe ithree institute, University of Technology Sydney, Ultimo, New South Wales, 2007, Australia.
James J LazenbyMicrobes in the Food Chain Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Cynthia B WhitchurchThe ithree institute, University of Technology Sydney, Ultimo, New South Wales, 2007, Australia.
University of Technology Sydney · AUNorwich Research Park · GBUniversity of East Anglia · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural transformation is a mechanism that enables competent bacteria to acquire naked, exogenous DNA from the environment. It is a key process that facilitates the dissemination of antibiotic resistance and virulence determinants throughout bacterial populations.

Indexed as

BiofilmsTransformation, BacterialBacterial ProteinsDNAFimbriae, BacterialPseudomonas aeruginosaBacterial ProteinsDNAeDNA, genomic DNAextracellular DNAgDNA, horizontal gene transferHGT, type IV piliT4P

Identifiers

PMID32749953
PMCPMC7660920
OpenAlexW3046991652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.